bluebird bio Inc (DELISTED) (BLUE:DL)
4.97
0.00 (0.00%)
USD |
NASDAQ |
Jun 06, 16:00
bluebird bio EPS Diluted (Quarterly): -2.981 for March 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Abbott Laboratories | 0.9146 |
| CervoMed, Inc. | -0.8351 |
| RxSight, Inc. | -0.2396 |
| Protalix Biotherapeutics, Inc. | 0.0291 |
| Armata Pharmaceuticals, Inc. | -0.7363 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -29.07M |
| Revenue (Quarterly) | 38.71M |
| Total Expenses (Quarterly) | 67.78M |
| Enterprise Value | 42.39M |
| Gross Profit Margin (Quarterly) | 68.39% |
| Profit Margin (Quarterly) | -75.09% |
| Earnings Yield | -410.9% |
| Normalized Earnings Yield | -400.06 |